Overview
- The first authoritative book dedicated to the understanding of cholesterol and its effect on the body
- Provides a comprehensive overview of cholesterol crystal formation and methods for detection and treatment
- Discusses cholesterol and its effect across multiple diseases
Part of the book series: Contemporary Cardiology (CONCARD)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
About this book
Cholesterol Crystals in Atherosclerosis and Other Related Diseases will be of interest to cardiologists as well as individuals in various fields of science including crystallography, basic and clinical imaging, cardiac oncology, and drug discovery.
Keywords
Table of contents (25 chapters)
-
Overview
-
Physical Properties and Imaging of Cholesterol Crystals: In Vitro
-
Physical Properties and Imaging of Cholesterol Crystals: In Vivo
-
Lipidology of Atherosclerosis
-
Cholesterol Crystals and Tissue Injury
Editors and Affiliations
About the editors
Department of Medicine, Cardiology
B208 Clinical Center, East Lansing, MI 48824
Phone: 517-353-1754; Fax: 517-353-4978;
email: abela@msu.edu
Stefan Mark Nidorf, M.B.B.S., F.R.A.C.P., M.D.
Cardiologist
Sir Charles Gairdner Hospital
The Heart and Vascular Research Institute
3/140 Mount Bay Rd
Perth, Western Australia 6000
(61+) 4803000
smnidorf@gmaiol.com
George S. Abela is a physician scientist and chief of cardiology at Michigan State University. He has conducted and authored the seminal research describing for the first time the critical role of cholesterol crystals in tissue injury. This was accomplished by demonstrating that cholesterol expands in volume when transformed from a liquid to solid state generating the hypothesis that this expansion in the confined environment of an atherosclerotic plaque can lead to rupture and erosion. Support data comes from demonstration of extensive crystals perforating ruptured plaques only in patients who died with myocardial infarction. Moreover, by modifying the tissue preparation process that avoids ethanol for scanning electron microscopy, he and lab co-workers were able to preserve the crystals from being dissolved by ethanol dehydration, a protocol that had been established centuries earlier. This unraveled the extent and severity of mechanical injury to the arterial wall by sharp tipped cholesterol crystals. He demonstrated that this process is not only present in coronary artery atherosclerotic plaques but also in cardiac valves, various solid cancers, brains from Alzheimer patients and most recently was found by other investigators in diabetic retinopathy. This universal process is a source of inflammation triggered by the transformation of cholesterol as a metastable molecule into a flat crystal. In a collaboration between Dr. Abela and immunologists, they demonstrated the role of cholesterol crystals in triggering inflammation via the NLRP3 inflammasome similar to the mechanism described for uric acid crystals. Overall, atherosclerosis as a crystalloid disease was recognized based on the discoveries made in Dr. Abela’s laboratory at Michigan State University.
Stefan Mark Nidorf is a clinical cardiologist practicing in Perth Western Australia affiliated the Heart and Vascular Research Institute at the Perkins Research Institute. His clinical research interest in atherosclerosis led him to initiate the LoDoCo trials of low dose colchicine for the secondary prevention of chronic coronary disease, the rationale of which has been strengthened by an improved understanding of how cholesterol transitions from an essential molecule into a crystalline form that can act toinitiate and perpetuate the chronic and acute manifestations of atherosclerosis.
Bibliographic Information
Book Title: Cholesterol Crystals in Atherosclerosis and Other Related Diseases
Editors: George S. Abela, Stefan Mark Nidorf
Series Title: Contemporary Cardiology
DOI: https://doi.org/10.1007/978-3-031-41192-2
Publisher: Humana Cham
eBook Packages: Medicine, Medicine (R0)
Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2023
Hardcover ISBN: 978-3-031-41191-5Published: 23 November 2023
Softcover ISBN: 978-3-031-41194-6Due: 24 December 2023
eBook ISBN: 978-3-031-41192-2Published: 22 November 2023
Series ISSN: 2196-8969
Series E-ISSN: 2196-8977
Edition Number: 1
Number of Pages: XV, 504
Number of Illustrations: 7 b/w illustrations, 148 illustrations in colour
Topics: Cardiology, Internal Medicine